PMID: 9184818May 1, 1997Paper

The effects of amrinone and glucagon on verapamil-induced myocardial depression in a rat isolated heart model

General Pharmacology
Y TuncokA Gure

Abstract

1. We measured the ability of glucagon and amrinone, used alone and in combination, to improve the myocardial function in a rat isolated heart model of calcium channel blocker (CCB) cardiotoxicity. 2. Verapamil 10(-4) mol consistently decreased heart rate and cardiac contractile force in our Langendorff rat isolated heart preparations. Glucagon increased the heart rate in a dose-dependent fashion. Amrinone increased the heart rate only at the 1 x 10(-1) mol concentration, and had no significant effect on cardiac contractility. 3. A positive linear correlation was found between the glucagon concentration and the percent recovery of baseline contractile force. 4. Although complete reversal of verapamil-induced myocardial depression occurred at glucagon concentrations of > 3 x 10(-6) mol, amrinone produced only 23.8 +/- 3.6% recovery from baseline at its highest concentration (4 x 10(-3) mol). 5. When glucagon and amrinone were administered together, there was no additional increase over glucagon alone in the increase in contractile force. 6. Glucagon, and not amrinone, is an appropriate agent, capable of reversing verapamil-induced myocardial toxicity in this rat isolated heart model. In vivo studies should be performed to assess...Continue Reading

References

Sep 1, 1992·British Journal of Pharmacology·H DongS X Peng
Sep 1, 1992·The American Journal of Emergency Medicine·T L LitovitzB F Schmitz
Sep 1, 1991·The American Journal of Emergency Medicine·T L LitovitzW Klein-Schwartz
Nov 1, 1989·The American Journal of Emergency Medicine·B Z Horowitz, K J Rhee
Sep 1, 1989·Canadian Journal of Physiology and Pharmacology·E DagherC Chartrand
Jul 1, 1988·European Heart Journal·G KisslingR Jacob
Mar 1, 1988·Critical Care Medicine·A L ZaritskyB Chernow
Nov 15, 1986·The American Journal of Cardiology·M GoenenJ Bonte
Jun 1, 1968·Circulation Research·B R Lucchesi
Jun 1, 1983·The Journal of Trauma·M K McLeodD S Gann
Mar 1, 1995·Annals of Emergency Medicine·C K StoneR Carroll
Nov 1, 1993·The Journal of Pharmacology and Experimental Therapeutics·J A KlineR M Raymond
Feb 1, 1993·Annals of Emergency Medicine·E A RamoskaD Borys
Jul 1, 1993·Annals of Emergency Medicine·L R WolfE J Otten

❮ Previous
Next ❯

Citations

Sep 30, 2003·Journal of Toxicology. Clinical Toxicology·Benoit Bailey
May 19, 2005·Toxicological Reviews·Christopher R DeWitt, Javier C Waksman
Aug 27, 2005·Human & Experimental Toxicology·D M WoodP I Dargan
Jan 22, 2003·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Steven D Salhanick, Michael W Shannon
Jun 29, 2007·Drugs in R&D·Gilles Hanton

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.

Related Papers

Drug Safety : an International Journal of Medical Toxicology and Drug Experience
Steven D Salhanick, M Shannon
© 2021 Meta ULC. All rights reserved